Product Information

CEPHALEXIN 250 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.7640 per EA under NDC 67877089101. Its NADAC has been published 89 times since Dec 11, 2024.

FDA first approved this application on Sep 27, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Cephalexin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CEPHALEXIN 250 MG TABLET

Cephalexin
$0.7640per EA
High Outlier

Strength

250 mg/1

NDC

67877089101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CEPHALEXIN

Approval Type

Generic (ANDA)

FDA Application

ANDA218947

FDA Approved

9/27/2024

TE Code

AB

On Market Since

10/21/2024

Pharmacological Classes

Price Statistics

The NADAC for CEPHALEXIN 250 MG TABLET has been published 89 times since Dec 11, 2024, and over the history we have for it it has declined 12.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7640 per EA
All-time high$0.9351 (Dec 10, 2025)
All-time low$0.6858 (Apr 22, 2026)
52-week high$0.9351
52-week low$0.6858
Median price$0.9106
Average price$0.8454
Largest weekly change-19.7% (Dec 17, 2025)
Weeks tracked89
Tracking sinceDec 11, 2024

Price History

1W

-3.1%

1M

-3.1%

3M

+10.8%

6M

+5.4%

1Y

-18.3%

3Y

N/A

5Y

N/A

All

-12.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cephalexin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of CEPHALEXIN 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CEPHALEXIN 250 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.7640 per EA (NDC 67877089101), effective Aug 19, 2026.

How has the price of CEPHALEXIN 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for CEPHALEXIN 250 MG TABLET has declined 12.6%. It has been tracked across 89 weekly CMS publications since Dec 11, 2024.

What are the highest and lowest recorded NADAC prices for CEPHALEXIN 250 MG TABLET?

Since Dec 11, 2024, the NADAC for CEPHALEXIN 250 MG TABLET has ranged from a low of $0.6858 (Apr 22, 2026) to a high of $0.9351 (Dec 10, 2025), with a median of $0.9106 per EA.

Are there cheaper alternatives to CEPHALEXIN 250 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of CEPHALEXIN 250 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CEPHALEXIN 250 MG TABLET?

CEPHALEXIN 250 MG TABLET (NDC 67877089101) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.